Assaf Oron
Corporate Officer/Principal chez BIOMX INC.
Profil
Assaf Oron is currently the Chief Executive Officer & Director at Evofuel Ltd.
and the Chief Business Officer at BiomX, Inc. He previously served as the Chief Executive Officer at Chondrocyte Ltd., Senior Project Manager at POC Management Consulting, Executive VP-Corporate Development at Evogene Ltd., and Chief Business Officer at BiomX Ltd.
Mr. Oron received his undergraduate and graduate degrees from Tel-Aviv University.
Postes actifs de Assaf Oron
Sociétés | Poste | Début |
---|---|---|
BIOMX INC. | Corporate Officer/Principal | 28/10/2019 |
Evofuel Ltd. | Chief Executive Officer | 01/01/2012 |
Anciens postes connus de Assaf Oron
Sociétés | Poste | Fin |
---|---|---|
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Corporate Officer/Principal | 01/10/2019 |
EVOGENE LTD. | Corporate Officer/Principal | 01/01/2017 |
Chondrocyte Ltd. | Chief Executive Officer | 01/01/2006 |
POC Management Consulting | Corporate Officer/Principal | 01/01/2003 |
Formation de Assaf Oron
Tel-Aviv University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
EVOGENE LTD. | Health Technology |
BIOMX INC. | Health Technology |
Entreprise privées | 4 |
---|---|
POC Management Consulting | |
Evofuel Ltd. | |
Chondrocyte Ltd. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |